Summary
The effect of renal and/or hepatic dysfunction, and of concomitant spironolactone therapy, on seven commercial digoxin assays was evaluated in 45 patients taking both these drugs, and a comparison made with the digoxin concentrations measured using the same assays in 30 patients taking digoxin in the absence of spironolactone.
The study showed that increasing renal dysfunction resulted in increasing inaccuracy in assay results with the methods tested. The influence of concomitant spironolactone was to produce a further distortion, which was shown to be additive in patients with impaired renal and/or liver function.
The results highlight the unresolved specificity problems which persist in many, if not all, of the immunoassays currently offered to clinical laboratories which, if not recognised, could significantly influence digoxin therapy and patient management.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Abshagen U, Rennekamp H, Luszpinski G (1976) Pharmacokinetics of spironolactone in man. Naunyn Schmiederbergs Arch Pharmacol 296: 37–47
Abshagen U, van Grodzicki U, Hirschberger U, Rennekamp H (1977) Effect of enterohepatic circulation on the pharmacokinetics of spironolactone in man. Naunyn Schmiedebergs Arch Pharmacol 300: 281–287
Di Piro JT, Cote JR, Di Piro CR, Bustrack JA (1980) Spironolactone interference with digoxin radioimmunoassays in cirrhotic patients. Am J Hosp Pharm 37: 1518–1521
Dobbs RJ, Nicholson PW, Denham MJ, Dobbs SM, O'Neill CJA (1986) Therapeutic drug monitoring of digoxin: help or hindrance? Eur J Clin Pharmacol 31: 491–495
Drost RH, Plomp TA, Teunissen AJ, Maas AHJ, Maas RAA (1977) A comparative study of the homogenous enzyme immunoassay (EMIT) and two radioimmunoassays (RIA's) for digoxin. Clin Chim Acta 79: 557–567
Frewin DB, Marmanidis H, Lehmann DR, Morris RG (1986) Anomalous serum digoxin concentrations in patients with hepatic or renal dysfunction. Aust NZ J Med 16: 241–243
Graves SW, Brown B, Valdes R (1983) An endogenous digoxin-like substance in patients with renal impairment. Ann Int Med 99: 604–608
Huffman DH (1974) The effect of spironolactone and canrenone on the digoxin radioimmunoassay. Res Commun Chem Pathol Pharmacol 9: 787–790
Karim A (1978) Spironolactone: Disposition, metabolism, pharmacodynamics, and bioavailability. Drug Metab Rev 8: 151–188
Karim A, Zagarella J, Hribar J, Dooley M (1976) Spironolactone. I. Disposition and metabolism. Clin Pharmacol Ther 19: 158–169
Morris RG, Lagnado PY, Lehmann DR, Frewin DB, Glistak ML, Burnet RB (1987) Spironolactone as a source of interference in commercial digoxin immunoassays. Ther Drug Monit 9: 208–211
Nanji AA, Greenway DC (1985) Falsely raised plasma digoxin concentrations in liver disease. Br Med J 290: 432–433
Silber B, Sheiner LB, Powers JL, Winter ME, Sadee W (1979) Spironolactone-associated digoxin radioimmunoassay interference. Clin Chem 25: 48–50
Smith TW, Antman EM, Friedman PL, Blatt CM, Marsh JD (1984) Digitalis glycosides: mechanisms and manifestations of toxicity, part 1. Prog Cardiovasc Dis 26: 413–458
Soldin SJ (1986) Digoxin-issues and controversies. Clin Chem 32: 5–12
Soldin SJ, Stephey C, Giesbrecht E, Harding R (1986) Further problems with digoxin measurement. Clin Chem 32: 1591
Thomas RW, Maddox RR (1981) The interaction of spironolactone and digoxin: A review and evaluation. Ther Drug Monit 3: 117–120
Valdes R, Graves SW, Brown BA, Landt M (1983) Endogenous substance in newborn infants causing false positive digoxin measurements. J Pediatr 102: 947–950
Zeegers JJW, Maas AHJ, Willebrands AF, Kruyswijk HH, Jambroes G (1973) The radioimmunoassay of plasma-digoxin. Clin Chim Acta 44: 109–117
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morris, R.G., Frewin, D.B., Taylor, W.B. et al. The effect of renal and hepatic impairment and of spironolactone on digoxin immunoassays. Eur J Clin Pharmacol 34, 233–239 (1988). https://doi.org/10.1007/BF00540949
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00540949